Skip to content

MAP( Mean Arterial Pressure) and Mortality Relation in Patients With Heart Failure

Evaluation of the Relationship Between Mean Arterial Pressure (MAP) and Mortality in Patients With Heart Failure: A Perspective From Emergency Department Monitoring and Hospital Presentation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06515366
Enrollment
280
Registered
2024-07-23
Start date
2024-06-01
Completion date
2025-06-01
Last updated
2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

heart failure, mean arterial pressure, emergency department

Brief summary

Aim of this observational study is to evaluate the relationship between mean arterial pressure (MAP) and mortality in patients presenting to the emergency department with acute heart failure, focusing on emergency department monitoring and subgroup presentations. Our goal is to determine the impact of subgroup characteristics on mortality among patients presenting with heart failure in the emergency department, and to assess the predictive value and significance of MAP in predicting mortality.

Detailed description

After obtaining ethical approval, the study will commence within 2 weeks and continue for 1 year. Based on clinical statistics or general literature data, and considering sample size calculations, a total of 280 patients across 4 groups have been determined. Inclusion Criteria: Age 18 and above Patients presenting with symptoms of heart failure Exclusion Criteria: Age under 18 Patients presenting with ST-elevation myocardial infarction Patients with acute kidney failure Pregnant patients Patients with inaccessible data for the parameters under study Groups based on initial mean arterial pressure (MAP) upon hospital admission will be established as follows: \<65 mmHg, 66-80 mmHg, 81-100 mmHg, \>100 mmHg. Data including results of emergency department tests and pertinent findings will be recorded for patients in these groups. The 30-day mortality rates of these patients will be statistically evaluated based on their MAP values and the procedures performed during emergency department monitoring.

Interventions

None listed

Sponsors

Ankara Etlik City Hospital
CollaboratorOTHER_GOV
Saglik Bilimleri Universitesi
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

Age 18 and above Patients presenting with symptoms of heart failure

Exclusion criteria

Age under 18 Patients presenting with ST-elevation myocardial infarction Patients with acute kidney failure Pregnant patients Patients with inaccessible data for the parameters under study

Design outcomes

Primary

MeasureTime frameDescription
mortality1 monthpatients having mortaility within 1 month of follow up

Secondary

MeasureTime frameDescription
re-hospitalization1 monthpatients being re-hospitalized within 1 month after discharge from hospital

Countries

Turkey (Türkiye)

Contacts

Primary Contactgulsen akcay, ass. prof.
gulakcay@yahoo.com.tr+905052874949
Backup Contactelif hamzacebioglu kayisoglu, specialist
turkuaz-61@windowslive.com+905453300679

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026